The peptide synthesis market is experiencing significant growth, with a projected valuation of USD 520.0 million in 2023. According to the latest analysis, the market is set to expand rapidly, reaching USD 1.1 billion by 2033, reflecting a CAGR of 8% during the forecast period.
The surge in the market can be attributed to the increasing demand for peptide-based drugs, advancements in peptide synthesis technologies, and their growing applications across pharmaceuticals, biotechnology, and medical research. Peptides, which are chains of amino acids, have become critical components in the development of targeted therapies, especially for oncology, cardiovascular diseases, and hormonal therapies.
With the growing focus on personalized medicine and the rising prevalence of chronic diseases, peptide synthesis has garnered attention due to its ability to create specific, tailored therapeutic agents. The advancements in solid-phase peptide synthesis (SPPS) and automated peptide synthesizers have further improved the speed and efficiency of peptide production, making them more accessible for pharmaceutical development and clinical use.
Furthermore, biopharmaceutical companies are increasingly utilizing peptides for drug discovery, and the demand for peptide-based vaccines and diagnostics is expected to propel the market forward. As peptide-based treatments gain momentum, the market for peptide synthesis is poised to grow significantly, fueled by the need for high-quality, scalable peptide production solutions.
Key Takeaways:
- Market Growth: The peptide synthesis market is projected to grow from USD 520.0 million in 2023 to USD 1.1 billion by 2033, with a CAGR of 8%.
- Increasing Demand: The rising demand for peptide-based therapeutics in oncology, cardiovascular diseases, and hormonal treatments is driving market growth.
- Technological Advancements: Innovations in solid-phase peptide synthesis and automated systems are enhancing the efficiency and scalability of peptide production.
- Personalized Medicine: The shift toward personalized medicine and biopharmaceutical applications is boosting the adoption of peptide-based treatments.
The peptide synthesis market is well-positioned for sustained growth, driven by technological advancements and the expanding role of peptides in modern medicine, paving the way for breakthroughs in therapeutic development and personalized healthcare solutions.
Competitive Landscape
The multiple established companies and the presence of key players consolidate the market. In addition, due to the modernization of medical research and development projects and rising pharmaceutical manufacturing, the key competitors focus on providing effective products and services.
By adopting several marketing tactics and deep market research, the market players are increasing the sales of peptide synthesis products. Their marketing tactics are mergers, acquisitions, collaborations, and partnerships.
Recent Developments in the Market:
- On the recent Innovation of Greener Technology in slid-phase peptide synthesis, Novo Nordisk and Bachem Holding AG announced their partnership to replace N-dimethylformamide and reprotoxic.
- The United States-based Thermo Fisher Scientific has recently announced its biopharmaceutical research laboratories. These laboratories perform high throughput and liquid chromatography.
- In May 2022, Biohaven Pharmaceuticals and Pfizer Inc announced their agreement to manufacture advanced therapy for dual-acting migraine to treat patients and prevent episodic migraine.
- In May 2022, LOTTE Corporation acquired Bristol Myers to grow New York-based plant production by adopting novel biologics.
- In February 2022, Plexium and Amgen announced their collaboration to generate protein degradation therapeutics and molecular glue therapeutics.
Other Prominent Players Operating in the Market are
- GenScript Biotech Corporation
- Bachem Holding AG
- Thermo Fisher Scientific Inc
- Merck KGaA
- Kaneka Corporation
Get Complete Full Report
Peptide Synthesis Market by Category
- 1. Executive Summary | Peptide Synthesis Market
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
- 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Service
- 5.1. Reagents
- 5.2. Equipment
- 5.3. Services
- 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology
- 6.1. Solid-Phase Peptide Synthesis
- 6.2. Solution-Phase Peptide Synthesis
- 6.3. Hybrid & Recombinant Technology
- 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End Use
- 7.1. Pharmaceuticals & Biotechnology Companies
- 7.2. CDMOs & CROs
- 7.3. Academics & Research Institutes
- 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. Asia Pacific
- 8.5. Middle East and Africa
- 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
- 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
- 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
- 12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
- 13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
- 14. Key Countries Market Analysis
- 15. Market Structure Analysis
- 16. Competition Analysis
- 17. Assumptions & Acronyms Used
- 18. Research Methodology
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
